When biotech acquisitions spike, early-stage startups are targets; Seagen CEO resigns after arrest on domestic assault charges

The last time there was a big wave of biotech acquisitions, buyers snapped up early-stage companies much more often than usual, a STAT analysis shows. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: When biotech acquisitions spike, early-stage startups are prime targets, analysis shows By Kate Sheridan Molly Ferguson for STAT The last time there was a big wave of biotech acquisitions, buyers snapped up early-stage companies much more often than usual. Read More STAT+: Seagen CEO resigns after arrest on domestic assault charges By Damian Garde Getty Images for Gabrielle's Angel Foundation Clay Siegall was arrested April 23 after police said he repeatedly shoved his wife to the ground during a late-night dispute. Read More Listen: A 'city on fire': How Miami shaped a disputed diagnosis used to justify deaths in police custody By Nicholas St. Fleur Keisha Okafor for STAT People with excited delirium are said to display "superhuman strength." But most medical authorities do not think excited delirium is real. Read More Sponsor content by YouTube Helping people find supportive stories and helpful mental health information Global rates of those experiencing mental health issues are on the rise. YouTube is putting a spotlight on content that can help normalize mental health. Explore how the YouTube community is sharing supportive stories and helpful information this May Mental Health Awareness Month. Puzzling pediatric hepatitis cases echo an earlier mysterious illness By Helen Branswell Cynthia S. Goldsmith, Yiting Zhang/CDC via AP, File Experts looking into the hepatitis cases believe there are lessons to be learned from the ongoing efforts to solve the mysteries of AFM. Read More STAT+: Google taps FDA's former digital health chief for global strategy role By Casey Ross Michael J. Ermarth/FDA Bakul Patel, a 13-year veteran of the FDA, will serve as Google’s senior director for global digital health strategy and regulatory affairs. Read More FDA rejects antidepressant seen as possible Covid-19 treatment By Jason Mast Adobe In an unusual two-page summary, regulators said doctors failed to provide adequate evidence of effectiveness of the drug, called fluvoxamine. Read More STAT+: Apollo acquires minority stake in Sofinnova, extending private equity dealmaking in life sciences By Allison DeAngelis Adobe Sofinnova is the third major biopharma venture capital firm to make a private equity deal in the last seven months. Read More STAT+: Two dozen states side with HHS in its raucous dispute with pharma over a drug discount program By Ed Silverman Adobe In 2020, several drugmakers began limiting some discounts when hospitals bought medicines and then shipped them to contract pharmacies. Read More Monday, May 16, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser